Cardiovascular Digital Solutions

Global Cardiovascular Digital Solutions Market to Reach US$126.9 Billion by 2030

The global market for Cardiovascular Digital Solutions estimated at US$92.4 Billion in the year 2024, is expected to reach US$126.9 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Unobtrusive Testing Service, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$73.0 Billion by the end of the analysis period. Growth in the CVD Health Informatics Service segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$25.2 Billion While China is Forecast to Grow at 8.7% CAGR

The Cardiovascular Digital Solutions market in the U.S. is estimated at US$25.2 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$25.6 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Cardiovascular Digital Solutions Market – Key Trends & Drivers Summarized

Why Are Cardiovascular Digital Solutions Redefining the Delivery and Monitoring of Cardiac Care?
Cardiovascular digital solutions are transforming the prevention, diagnosis, and management of heart diseases through data-driven, connected, and patient-centric technologies. These solutions span a broad spectrum—from wearable ECG monitors and AI-powered diagnostic platforms to remote patient monitoring (RPM), digital therapeutics, and cloud-based cardiac imaging systems. As cardiovascular disease continues to be the leading global cause of mortality, digital solutions are becoming indispensable in improving clinical outcomes, enabling early detection, and enhancing care accessibility across both acute and chronic cardiac conditions.

The convergence of mobile health apps, smart sensors, and real-time analytics is allowing continuous tracking of key cardiac indicators such as heart rate variability, blood pressure, arrhythmias, and medication adherence. These capabilities are empowering both clinicians and patients to proactively manage cardiovascular risk and treatment, reducing hospital readmissions and enabling cost-effective chronic disease management within home and outpatient settings.

How Are AI, Cloud Platforms, and Interoperability Driving Innovation and Integration in Cardiovascular Care?
Artificial intelligence and machine learning are central to the evolution of cardiovascular digital solutions, enabling automated ECG interpretation, early detection of atrial fibrillation and heart failure exacerbations, and personalized care recommendations. Clinical decision support systems (CDSS) powered by AI are assisting cardiologists with risk stratification, diagnostic accuracy, and optimized treatment planning.

Cloud-based platforms are enhancing accessibility and scalability of cardiovascular data, enabling remote diagnostics, second opinions, and population health analytics. These platforms are increasingly designed with interoperability in mind, integrating seamlessly with EHR systems, imaging software, wearable devices, and health information exchanges (HIEs). This integration allows for comprehensive, real-time visibility across the patient care continuum, facilitating coordinated interventions and improved care quality.

Where Is Demand for Cardiovascular Digital Solutions Accelerating and Which Use Cases Are Leading Adoption?
North America and Europe are leading adoption, driven by digital health maturity, favorable reimbursement models, and high cardiovascular disease prevalence. The U.S. market, in particular, is characterized by widespread deployment of RPM programs for heart failure and post-acute care, alongside strong uptake of wearable ECG monitors and virtual cardiac rehabilitation tools. Europe follows closely with growing use of telecardiology, AI-based imaging analysis, and integrated digital heart health platforms.

Asia-Pacific is emerging as a high-growth region, with rapid urbanization, increased mobile health usage, and government initiatives in digital healthcare infrastructure. Key use cases include home-based monitoring of heart failure and hypertension, early arrhythmia detection, virtual follow-up for cardiac procedures, and digital interventions for lifestyle modification. Cardiology practices, specialty clinics, health systems, and medtech innovators are leveraging these tools to extend reach and personalize cardiac care delivery.

What Is Fueling the Global Growth of the Cardiovascular Digital Solutions Market?
The global cardiovascular digital solutions market is expanding in response to rising chronic disease burdens, aging populations, healthcare digitization, and the shift toward value-based care. Increased awareness of cardiovascular risk factors and the growing demand for continuous, non-invasive monitoring are driving adoption across preventive, acute, and post-discharge cardiac care.

Strategic partnerships between health tech firms, device manufacturers, hospitals, and payers are accelerating solution development, integration, and reimbursement. Venture capital funding and government incentives are further stimulating innovation in wearable biosensors, mobile cardiology platforms, and AI-powered decision tools. As digital health becomes foundational to cardiovascular care models, a defining question emerges: Can cardiovascular digital solutions achieve scale, accuracy, and interoperability—while delivering measurable clinical impact and system-level efficiencies across global cardiac care ecosystems?

SCOPE OF STUDY:

The report analyzes the Cardiovascular Digital Solutions market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Service (Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs); Component (Devices, Software); End-User (Healthcare Organization, Healthcare Consumer, Other End-Users)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Abbott Laboratories
• AliveCor, Inc.
• Apple Inc.
• Bardy Diagnostics, Inc.
• Baxter International Inc.
• BioSerenity
• BioTelemetry, Inc.
• Cardiac Insight Inc.
• Cardiotrack (Uber Diagnostics)
• Eko Health Inc.
• GE HealthCare Technologies Inc.
• HeartFlow, Inc.
• Hello Heart
• iRhythm Technologies, Inc.
• Koninklijke Philips N.V.
• Medtronic plc
• Siemens Healthineers AG
• Verily Life Sciences LLC
• Vista.ai (HeartVista, Inc.)
• Withings

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.